The Cancer Immunotherapy Revolution: The Principles, Advances and Practical Toxicity Management

Join us on 24 and/or 27 January for the 2-day immunotherapy hybrid study day

Advances in immunotherapy have revolutionised treatments for many cancer types. This has resulted in the need to improve immunotherapy knowledge from the impact in cancer medicine to challenges in managing patients on these treatments.

This 2-day event will bring together expertise in the immuno-oncology field to discuss topics from basic principles of tumour immunology to clinical application and toxicity management in practice.

Friday 24 and Monday 27 January 2025, 9am to 5pm GMT

Join us on 24 and/or 27 January for the 2-day Immunotherapy Hybrid Study Day.

What to expect

24 January 2025:

An overview of the cancer immunity cycle
The successes of immune checkpoint inhibitors
What is on the horizon for immunotherapies?

27 January 2025:

Recognising and managing immunotherapy toxicities

Intended audience

Health care professionals involved in treating patients on immunotherapy, academics involved in cancer research or anyone with an interest in this field.

Prices

2-day attendance:
- Early bird: £120
- Full price: £140
1-day attendance virtual and on-demand:
- Early bird: £65
- Full price: £80
1-day attendance on-site delegate (including lunch):
- Early bird: £65
- Full price: £80
2-day attendance onsite/virtual: offer 5 for 4: £112 per ticket
2-day attendance student/charity (virtual/on-demand): £100
2-day attendance low and middle-income countries (LMIC) (virtual/on-demand): £80
2 day attendance pharma and industry (virtual/on-demand): £300

All tickets (on-site and virtual) include access to the event recordings, resources and presentations for up to 6 months post-event date.

Education events sponsorship opportunities

If you are interested in sponsorship opportunities, see how you can support the development of cancer education and patient care.